Download eBook for Free

FormatFile SizeNotes
PDF file 4.5 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.


Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback215 pages $28.00 $22.40 20% Web Discount

This study aims to identify which medications deserve priority for clinical research in the short term. The authors found that a lot of knowledge is already available and needs dissemination rather than further research. The medication for ADHD, Ritalin is the best example of this. However, many medications have not been studied yet in children and among those, two research questions are identified: 1 - clinical research on the safety, effectiveness and long term effects of (amongst others) psycho-active substances, new anti-epileptics and gastro-intestinal medications for use in children 2 - dissemination of knowledge on several medications to paediatricians, general practitioners and pharmacists.

Table of Contents

  • Summary

  • Preface

    All Prefatory Materials

  • Chapter 1


  • Chapter 2


  • Chapter 3


  • Nawoord

  • Literatuurlijst

  • Appendix A

    Lijst GeÏNterviewden

  • Appendix B

    Schriftelijke Vragenlijst

  • Appendix C

    Analyse Schriftelijke Vragenlijst

  • Appendix D


  • Appendix E

    Scorelijst Inhoudelijke Commissie

  • Appendix F


Research conducted by

The research described in this report was performed under the auspices of RAND Europe.

This report is part of the RAND Corporation Monograph report series. The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.